<p>Representative examples of antiviral inhibition curves in a multiple cycle replication assay for A) BVM, B) BMS-1 and C) BMS-955176 toward WT, V362I, V370A and ΔV370 viruses. Maximal percent inhibition (MPI) values were calculated from the plateaus in inhibition at the highest inhibitor concentration, and tabulated and normalized for multiple experiments in <a href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1005990#ppat.1005990.t002" target="_blank">Table 2</a> using the equation MPI = (1 - (signal from the average at the two highest drug concentrations/signal from no drug control) * 100). Units are in <i>Renilla</i> luciferase relative light units (RLU). In cases where there is no curve, and thus no plateau <i>p...
<p>(A) The bnMAbs are ordered from left to right according to decreasing medians of percent maximum ...
<p>Virus inhibition assays were performed in PFA (A), MDM (B) and PBMC (C) using titrating amounts o...
<p>The two regimens with repeat doses are compared to a single dose in Panel C.</p
l e t t e r s nature medicine advance online publication Highly active antiretroviral therapy (HAART...
Colored lines depict the concentration-prophylaxis profile for an average drug class-specific slope ...
<p>Curves represent the sigmoidal fittings of the data, obtained in triplicates, on PmV inhibition b...
<p>(<b>A</b>) Heat map showing relative percent infection inhibition (left panel) and percent cell n...
Estimated inhibition percentage (A), percentage reduction in the basic reproduction number R0 (B) an...
<p>(A) Each point on the graph represents the percent at which the neutralization curve plateaued fo...
(A & B) For determination of virus replication, A549 cells were pre-treated with small molecules at ...
<p>(A) The bnMAbs are ordered from left to right according to decreasing medians of MPN. Each point ...
<p>Comparison of the combination of different doses of both compounds necessary to reach 50% replica...
<p>The effect of the drugs AZT, EFV and NVP on mutant viruses pNL4-3<sub>T369A</sub> and pNL4-3<sub>...
a<p>The required concentration to reduce 50% of plaque formation (EC<sub>50</sub>) was calculated by...
10M ddC, or mock treated (0 μg SP4-2), as indicated. Then, cells were infected with HIV-1 (NL4-3) at...
<p>(A) The bnMAbs are ordered from left to right according to decreasing medians of percent maximum ...
<p>Virus inhibition assays were performed in PFA (A), MDM (B) and PBMC (C) using titrating amounts o...
<p>The two regimens with repeat doses are compared to a single dose in Panel C.</p
l e t t e r s nature medicine advance online publication Highly active antiretroviral therapy (HAART...
Colored lines depict the concentration-prophylaxis profile for an average drug class-specific slope ...
<p>Curves represent the sigmoidal fittings of the data, obtained in triplicates, on PmV inhibition b...
<p>(<b>A</b>) Heat map showing relative percent infection inhibition (left panel) and percent cell n...
Estimated inhibition percentage (A), percentage reduction in the basic reproduction number R0 (B) an...
<p>(A) Each point on the graph represents the percent at which the neutralization curve plateaued fo...
(A & B) For determination of virus replication, A549 cells were pre-treated with small molecules at ...
<p>(A) The bnMAbs are ordered from left to right according to decreasing medians of MPN. Each point ...
<p>Comparison of the combination of different doses of both compounds necessary to reach 50% replica...
<p>The effect of the drugs AZT, EFV and NVP on mutant viruses pNL4-3<sub>T369A</sub> and pNL4-3<sub>...
a<p>The required concentration to reduce 50% of plaque formation (EC<sub>50</sub>) was calculated by...
10M ddC, or mock treated (0 μg SP4-2), as indicated. Then, cells were infected with HIV-1 (NL4-3) at...
<p>(A) The bnMAbs are ordered from left to right according to decreasing medians of percent maximum ...
<p>Virus inhibition assays were performed in PFA (A), MDM (B) and PBMC (C) using titrating amounts o...
<p>The two regimens with repeat doses are compared to a single dose in Panel C.</p